The trademark FEMARIST was filed by Aristo Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 31, 2017, and received one opposition filed on June 28, 2017 by Novartis AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 28, 2017
The application was filed in Spanish, and Spanish was also language of all opposition proceedings (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on November 19, 2018. A transfer of the trademark registration was recorded on January 16, 2019.
The Appeal with reference B R0182/2019-5 was Opposition allowed according to Article 8(1)(b) EUTMR with decision issued on November 5, 2019 by the EUIPO. The Opposition with reference B 002918665 was partially refused EUTMA/IR according to Article 8(1)(b) EUTMR with decision issued on November 28, 2018 by the EUIPO.